Earnouts v2 Know when to use Earnouts to reduce risk, break a negotiation deadlock and get it done. Negotiation Whitepapers methodology
Capital Raising the Investor Landscape Start writing here...... Capital to raise Investment Whitepapers
Demystifying M&A Valuation Chinese 估值是每笔交易中最关键的部分,但它往往是最不被理解的部分。与Ascento Capital的管理合伙人本·博伊塞万(Ben Boissevain)一起探讨估值的细微差别、估值框架以及正确估值的流程。 Mergers & Acquisitions Valuation Whitepapers
Demystifying Tech M&A Valuation korean 가치 평가는 모든 거래에서 가장 중요한 부분이지만 중요한 만큼 이해가 어려운 분야입니다. 아센토 캐피털의 매니징 파트너인 벤 보이세빈 (Ben Boissevain)과 함께 "가치 평가"라는 단어의 의미, 개요 및 가치 평가를 성공적으로 처리하기 위한 과정을 알아보십시오. Technology Valuation Whitepapers
Essential Steps to Successful Biopharma Partnering This whitepaper provides a strategic perspective coupled with actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering. BioPharma Licensing & Partnering Life Sciences Whitepapers
Valuation of Your Early Drug Candidate In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner. Life Sciences Series Valuation Whitepapers
Getting Ready for a Biopharma Partnering Deal This whitepaper provides actionable advice for Biotech business development leaders on how to get ready for a partnering deal. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
Must-Know Finance Concepts for Life Sciences Valuations - Part II This whitepaper discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value. Best Practices & Trends BioPharma Life Sciences Valuation Whitepapers
Demystifying Tech M&A Valuation In this whitepaper, explore the nuances of valuation, its framework and the processes for getting it right. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Valuation Whitepapers
Must-Know Finance Concepts for Life Sciences Valuations This whitepaper presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets. Best Practices & Trends BioPharma Life Sciences Valuation Whitepapers
The Nuts & Bolts of Due Diligence in Biopharma Partnering This whitepaper focuses on best practices in due diligence with the goal of forming productive biopharma partnerships. Best Practices & Trends BioPharma Due Diligence Licensing & Partnering Life Sciences Series Whitepapers
How to Win at the Partnering Game In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers